Fifth Third Bancorp
LMAT icon

Fifth Third Bancorp’s LeMaitre Vascular LMAT Stock Holding History

Fifth Third Bancorp’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.6M Buy
161,084
+151,227
+1,534% +$14.4M 0.03% 335
2025
Q4 		$799K Sell
9,857
-172
-2% -$14.8K ﹤0.01% 658
2025
Q3 		$878K Sell
10,029
-759
-7% -$67.8K ﹤0.01% 672
2025
Q2 		$896K Sell
10,788
-115
-1% -$9.61K ﹤0.01% 625
2025
Q1 		$915K Buy
10,903
+246
+2% +$22.9K ﹤0.01% 599
2024
Q4 		$982K Sell
10,657
-435
-4% -$41.8K ﹤0.01% 586
2024
Q3 		$1.03M Buy
11,092
+204
+2% +$17.7K ﹤0.01% 600
2024
Q2 		$896K Buy
10,888
+678
+7% +$49.8K ﹤0.01% 615
2024
Q1 		$678K Buy
10,210
+91
+0.9% +$5.62K ﹤0.01% 683
2023
Q4 		$574K Sell
10,119
-130
-1% -$6.81K ﹤0.01% 713
2023
Q3 		$558K Hold
10,249
– – ﹤0.01% 702
2023
Q2 		$690K Sell
10,249
-3,526
-26% -$215K ﹤0.01% 648
2023
Q1 		$709K Buy
13,775
+182
+1% +$8.84K ﹤0.01% 636
2022
Q4 		$626K Sell
13,593
-71
-0.5% -$3.33K ﹤0.01% 645
2022
Q3 		$692K Buy
13,664
+35
+0.3% +$1.75K ﹤0.01% 622
2022
Q2 		$621K Buy
13,629
+29
+0.2% +$1.3K ﹤0.01% 625
2022
Q1 		$632K Sell
13,600
-169
-1% -$7.56K ﹤0.01% 659
2021
Q4 		$692K Buy
13,769
+229
+2% +$11.8K ﹤0.01% 645
2021
Q3 		$719K Buy
13,540
+401
+3% +$22.6K ﹤0.01% 621
2021
Q2 		$802K Buy
13,139
+196
+2% +$10.4K ﹤0.01% 613
2021
Q1 		$631K Buy
12,943
+66
+0.5% +$3.09K ﹤0.01% 639
2020
Q4 		$522K Buy
12,877
+408
+3% +$14.6K ﹤0.01% 658
2020
Q3 		$406K Sell
12,469
-9
-0.1% -$270 ﹤0.01% 675
2020
Q2 		$329K Buy
12,478
+9
+0.1% +$235 ﹤0.01% 723
2020
Q1 		$311K Sell
12,469
-4,009
-24% -$124K ﹤0.01% 707
2019
Q4 		$592K Buy
16,478
+60
+0.4% +$2.07K ﹤0.01% 620
2019
Q3 		$561K Hold
16,418
– – ﹤0.01% 618
2019
Q2 		$459K Buy
16,418
+44
+0.3% +$1.22K ﹤0.01% 652
2019
Q1 		$508K Buy
16,374
+7,107
+77% +$190K ﹤0.01% 607
2018
Q4 		$219K Buy
9,267
+1,067
+13% +$29.1K ﹤0.01% 832
2018
Q3 		$318K Buy
8,200
+8,155
+18,122% +$294K ﹤0.01% 778
2018
Q2 		$2K Hold
45
– – ﹤0.01% 2179
2018
Q1 		$2K Sell
45
-10
-18% -$346 ﹤0.01% 2183
2017
Q4 		$2K Buy
+55
New +$1.88K ﹤0.01% 2141

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fifth Third Bancorp's LMAT Position: Q1 2026 in Review

Fifth Third Bancorp increased its LeMaitre Vascular (LMAT) stake by 1,534% in Q1 2026, buying an estimated $14.4M and bringing the position to 161,084 shares worth $17.6M. The position accounts for 0.03% of the portfolio, ranked #335.

Fifth Third Bancorp first reported a position in LMAT in Q4 2017 and has held it in 34 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Fifth Third Bancorp held 161,084 shares of LeMaitre Vascular worth $17.6M as of Q1 2026.
  • Fifth Third Bancorp bought 151,227 LeMaitre Vascular shares in Q1 2026, an estimated $14.4M.
  • LeMaitre Vascular made up 0.03% of Fifth Third Bancorp's portfolio in Q1 2026, its #335 holding.
  • Fifth Third Bancorp first reported a position in LeMaitre Vascular in Q4 2017 and has held it in 34 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.